Clinical Trial Update: Transnasal Sphenopalatine Ganglion Block for Treatment of Acute Subarachnoid Hemorrhage Associated Headache [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update indicates that a transnasal sphenopalatine ganglion block is being studied for acute subarachnoid hemorrhage–associated headache, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Headache
• Subarachnoid Hemorrhage

Snippet

Sponsor: University of California, Davis | Conditions: SAH (Subarachnoid Hemorrhage), Headache | Phase 2, Phase 3 | Status: RECRUITING